# Jiangsu Xianlin Life Technology Innovation Park Development

Jiangsu Xianlin Life Technology Innovation Park Development is a Corporate Investor based in Nanjing, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Nanjing, China
- **Region:** Asia
- **Address:** 9 Weidi Road, Xianlin University City, Qixia District, Nanjing, Jiangsu, China
- **Assets under management:** Undisclosed
- **Website:** jslifetech.com

## Regulatory record

- **Reports private funds:** No

## About

Jiangsu Xianlin Life Technology Innovation Park Development is a corporate investor based in Nanjing, China. It manages $792.5 million in assets across 1 fund, primarily focusing on Asia.

## Sectors

- Digital Health
- Healthcare Services
- Life Sciences

## Questions

### How is Jiangsu Xianlin Life Technology Innovation Park Development structured as an investor?

The firm operates as a corporate investor with a real estate development core. Nanjing Southeast State-owned Assets Investment Group holds a significant stake, and the park generates exposure to life-science ventures through its incubator facilities and tenant relationships rather than through a conventional fund structure. Its returns are tied to both property performance and the success of the companies that lease lab and office space.

### What is the relationship between the park and Nanjing University?

Nanjing University and Nanjing University of Traditional Chinese Medicine serve as academic and research partners located in Xianlin University City. They supply the park with talent, joint research opportunities, and a pipeline of spinout companies that become tenants within the innovation park's lab and office facilities.

### Does the firm participate in fund commitments or only direct deals?

The firm's model centers on direct engagement with portfolio companies as tenants and incubator residents. The Jiangsu High-tech Entrepreneurship Service Center co-built a state-level incubator on-site, creating a mechanism for the park to support startups directly without operating a traditional venture capital fund that makes third-party limited partner commitments.

### Which sectors does the innovation park target?

The park focuses on life sciences, biomedical innovation, and pharmaceutical development. Tenant companies such as Jiangsu Aidea Pharmaceutical and Nanjing Ansailai Pharmaceutical Technology indicate a concentration on drug development and related biotech fields within the broader life-science ecosystem.

## Related profiles

- [Jiangsu Wujin High-Tech Investment Holdings](https://altss.com/profile/jiangsu-wujin-high-tech-investment-holdings)
- [Jiangsu Xinhaicheng Development Group](https://altss.com/profile/jiangsu-xinhaicheng-development-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/jiangsu-xianlin-life-technology-innovation-park-development

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology